Department of Cardiovascular Medicine, National Hospital Organization Ureshino Medical Center, Saga, Japan; Department of Cardiovascular Medicine, Saga University, Saga, Japan.
Department of Cardiovascular Medicine, Saga University, Saga, Japan.
Int J Cardiol. 2022 Jan 1;346:1-7. doi: 10.1016/j.ijcard.2021.11.046. Epub 2021 Nov 19.
In-hospital bleeding is associated with poor prognosis in patients with acute myocardial infarction (AMI). We sought to investigate whether a combination of pre-procedural blood tests could predict the incidence of in-hospital major bleeding in patients with AMI.
A total of 1684 consecutive AMI patients who underwent primary percutaneous coronary intervention (PCI) were recruited and randomly divided into derivation (n = 1010) and validation (n = 674) cohorts. A risk-score model was created based on a combination of parameters assessed on routine blood tests on admission. In the derivation cohort, multivariate analysis revealed that the following 5 variables were significantly associated with in-hospital major bleeding: hemoglobin level < 12 g/dL (odds ratio [OR], 3.32), white blood cell count >10,000/μL (OR, 2.58), platelet count <150,000/μL (OR, 2.51), albumin level < 3.8 mg/dL (OR, 2.51), and estimated glomerular filtration rate < 60 mL/min/1.73 m (OR, 2.31). Zero to five points were given according to the number of these factors each patient had. Incremental risk scores were significantly associated with a higher incidence of in-hospital major bleeding in both cohorts (P < 0.001). Receiver operating characteristic curve analysis of risk models showed adequate discrimination between patients with and without in-hospital major bleeding (derivation cohort: area under the curve [AUC], 0.807; 95% confidence interval [CI], 0.759-0.848; validation cohort: AUC, 0.793; 95% CI, 0.725-0.847).
Our novel laboratory-based bleeding risk model could be useful for simple and objective prediction of in-hospital major bleeding events in patients with AMI.
院内出血与急性心肌梗死(AMI)患者的预后不良有关。我们旨在探究术前血液检查的组合是否可预测 AMI 患者院内大出血的发生率。
共纳入 1684 例接受直接经皮冠状动脉介入治疗(PCI)的连续 AMI 患者,并将其随机分为推导(n=1010)和验证(n=674)队列。根据入院时常规血液检查评估的参数,建立风险评分模型。在推导队列中,多变量分析显示,以下 5 个变量与院内大出血显著相关:血红蛋白水平<12g/dL(比值比 [OR],3.32)、白细胞计数>10,000/μL(OR,2.58)、血小板计数<150,000/μL(OR,2.51)、白蛋白水平<3.8mg/dL(OR,2.51)和估计肾小球滤过率<60mL/min/1.73m(OR,2.31)。根据每位患者存在这些因素的数量,给予 0-5 分。在两个队列中,递增风险评分与院内大出血发生率的升高显著相关(P<0.001)。风险模型的接收者操作特征曲线分析显示,模型在区分有无院内大出血的患者方面具有良好的区分能力(推导队列:曲线下面积 [AUC],0.807;95%置信区间 [CI],0.759-0.848;验证队列:AUC,0.793;95%CI,0.725-0.847)。
我们的新型基于实验室的出血风险模型可用于简单、客观地预测 AMI 患者院内大出血事件。